Cysteamine Decreases Prolactin Responsiveness to Thyrotropin‐Releasing Hormone in Normal Men
暂无分享,去创建一个
[1] W. Gahl,et al. Blunted prolactin response to thyrotropin-releasing hormone stimulation in cystinotic children receiving cysteamine. , 1985, The Journal of clinical endocrinology and metabolism.
[2] V. Beral,et al. PREGNANCY OUTCOME IN INSULIN-DEPENDENT DIABETICS WITH THYROID DISEASE OR PERNICIOUS ANAEMIA , 1984, The Lancet.
[3] J. Scammell,et al. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity. , 1984, Endocrinology.
[4] S. Shin,et al. Cysteamine acts immediately to inhibit prolactin release and induce cellular changes in estradiol-primed male rats. , 1984, Neuroendocrinology.
[5] W. Millard,et al. Cysteamine induces depletion of both immunological and biological prolactin activity in the anterior pituitary and blood of the rat. , 1983, Endocrinology.
[6] S. Goldfarb,et al. Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent). , 1983, The New England journal of medicine.
[7] M. Lorenson,et al. Detectability of pituitary PRL and GH by immunoassay is increased by thiols and suppressed by divalent cations. , 1983, Endocrinology.
[8] L. Grouse,et al. Cysteamine Blocks Somatostatin Secretion Without Altering the Course of Insulin or Glucagon Release: A New Model for the Study of Islet Function , 1983, Diabetes.
[9] J. B. Martin,et al. The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the rat. , 1983, Endocrinology.
[10] J. B. Martin,et al. Cysteamine: a potent and specific depletor of pituitary prolactin. , 1982, Science.
[11] S. Szabó,et al. Selective depletion of somatostatin in rat brain by cysteamine , 1982, Brain Research.
[12] A. F. Stewart,et al. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. , 1982, The New England journal of medicine.
[13] J. B. Martin,et al. Cysteamine reduces serum gonadotropin concentrations in adult male rats. , 1982, Life sciences.
[14] S. Szabó,et al. Somatostatin in rat tissues is depleted by cysteamine administration. , 1981, Endocrinology.
[15] J. Schulman,et al. Pantetheinase Activity and Cysteamine Content in Cystinotic and Normal Fibroblasts and Leukocytes , 1981, Pediatric Research.
[16] A. Brodrick,et al. THE STABILITY OF AN ORAL LIQUID FORMULATION OF CYSTEAMINE , 1981, Journal of clinical and hospital pharmacy.
[17] M. Yudkoff,et al. Effects of cysteamine therapy in nephropathic cystinosis. , 1981, The New England journal of medicine.
[18] F. Maloof,et al. Metabolic clearance and production rates of prolactin in man. , 1979, The Journal of clinical investigation.
[19] P. Sönksen,et al. BROMOCRIPTINE SUPPRESSION OF TRH‐STIMULATED PROLACTIN AND THYROTROPHIN RELEASE AND ACCOMPANYING INHIBITION OF BROMOCRIPTINE INDUCED GROWTH HORMONE RELEASE BY TRH IN NORMAL MAN , 1979, Clinical endocrinology.
[20] B. Weintraub,et al. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. , 1976, The Journal of clinical endocrinology and metabolism.
[21] G. Sutherland,et al. CYSTEAMINE, METHIONINE, AND PENICILLAMINE IN THE TREATMENT OF PARACETAMOL POISONING , 1976, The Lancet.
[22] B. Weintraub,et al. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. , 1973, The Journal of clinical investigation.
[23] J. Schulman,et al. Adverse reactions to oral cysteamine use in nephropathic cystinosis. , 1981, Developmental pharmacology and therapeutics.